MTSC
Get informed when a big investor buys or sells
+ Follow| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $-14.16 |
| Beta | - |
| Outstanding Shares | 19,315,000 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 1.39 |
| Price to Book Ratio | 4.87 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | 2.48 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
As the most powerful economic committee, it controls taxation, trade, and entitlement spending, including Medicare pricing, which directly impacts the profitability and market for electromedical devices reimbursed by federal programs.
This committee directly allocates discretionary federal spending, determining the precise cash flow for agencies like the VA and NIH, which are major purchasers or funders of electromedical apparatus.
This committee directly regulates the FDA, which is the primary regulatory body for electromedical and electrotherapeutic apparatus, and influences NIH funding for medical research crucial to the industry.
This committee directly impacts government healthcare contractors and medical device manufacturers through its oversight and funding decisions for the Department of Veterans Affairs, which procures and uses such apparatus.